SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 457.82+1.3%Jan 23 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sense who wrote (176206)8/12/2021 8:16:57 PM
From: TobagoJack  Read Replies (1) of 219688
 
More alphabets on-rushing ...

zerohedge.com

New Studies Suggest Lambda Variant Could Be Vaccine-ResistantTwo separate studies have concluded that the latest Covid-19 fearpocalypse - the Lambda strain - may be vaccine resistant, as well as more infectious than the original alpha strain of SARS-CoV-2.

[url=][/url]

No word on how people with preexisting natural immunity fare against Lambda.

As the New York Post reports, a not-yet peer-reviewed study out of Japan published on July 28 concludes that the C.37 Lambda variant is defeating the 'leaky' vaccine at an alarming rate.

The strain has been contained in 26 countries, including substantial outbreaks in Chile, Peru, Argentina and Ecuador.


“Notably, the vaccination rate in Chile is relatively high; the percentage of the people who received at least one dose of COVID-19 vaccine was [about] 60%,” the authors write.


“Nevertheless, a big COVID-19 surge has occurred in Chile in Spring 2021, suggesting that the Lambda variant is proficient in escaping from the antiviral immunity elicited by vaccination,” they warn. -New York Post


The new variant is thought to have emerged between November and December 2020 in South America, and has since emerged in countries throughout Europe, North America and Asia according to data from GISAID. That said, it's only around one-tenth of 1% of cases in America, around 911 so far.

"In addition to increasing viral infectivity, the Delta variant exhibits higher resistance to the vaccine-induced neutralization," wrote the authors, adding "Similarly, here we showed that the Lambda variant equips not only increased infectivity but also resistance against antiviral immunity."

[url=][/url]

In a similar not-yet peer-reviewed study out of Chile, investigators concluded "that mutations present in the spike protein of the lambda variant of interest confer increased infectivity and immune escape from neutralizing antibodies elicited by CoronaVac."

CoronaVac is a vaccine manufactured by a Chinese company and that’s used in Peru. The study continues: “These data reinforce the idea that massive vaccination campaigns in countries with high SARS-CoV-2 circulation must be accompanied by strict genomic surveillance allowing the identification of new isolates carrying spike mutations and immunology studies aimed to determine the impact of these mutations in immune escape and vaccines breakthrough.”


Of note, Peru has the highest Covid-19 death rate of any country in the world - around 600 for every 100,000 people, about double the next highest country, Hungary. Around 81% of cases in Peru since April were the lambda variant, according to the WHO.

The news comes amid an Axios report that the Pfizer vaccine was just 42% effective in July - when the Delta variant was dominant. Meanwhile, 40% of migrants bused into Laredo, Texas are Covid-positive.

The next time you hear Fauci, Biden or Psaki warn how scary the Lambda strain is, ask yourself why they won't close the border - or mandate the 'efficacy challenged' vaccines they've bet the farm on.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext